Inventor · disambiguated record
Philip A. Leighton
Also filed as: LEIGHTON PHILIP · LEIGHTON PHILIP A · LEIGHTON PHILIP ALBERT
14 granted patents·17 pending applications·44 citations·filing 1998–2025
90Inventor score
Files withCRYSTAL BIOSCIENCE INC15SYNAGEVA BIOPHARMA CORP5ORIGEN THERAPEUTICS INC3LEIGHTON PHILIP A2ORIGEN THERAPEUTICS2
Top patents by PatentIndex Score
31 records- 0193US9809642B2Transgenic chicken comprising an inactivated immunoglobulin geneCRYSTAL BIOSCIENCE INC·Filed 2016·Granted Nov 7, 2017·7 cites·11 claims
- 0290US11337409B2Transgenic animal for producing diversified antibodies that have the same light chain ICRYSTAL BIOSCIENCE INC·Filed 2019·Granted May 24, 2022·4 cites·16 claims
- 0390US10687519B2Transgenic animal for production of antibodies having minimal CDRsCRYSTAL BIOSCIENCE INC·Filed 2019·Granted Jun 23, 2020·3 cites·15 claims
- 0490US10172334B2Transgenic animal for production of antibodies having minimal CDRSCRYSTAL BIOSCIENCE INC·Filed 2018·Granted Jan 8, 2019·4 cites·15 claims
- 0589US9549538B2Transgenic animal for production of antibodies having minimal CDRsCRYSTAL BIOSCIENCE INC·Filed 2016·Granted Jan 24, 2017·4 cites·15 claims
- 0687US11033009B2Transgenic chicken for production of antibodies having a common light chainCRYSTAL BIOSCIENCE INC·Filed 2016·Granted Jun 15, 2021·5 cites·7 claims
- 0784US10689433B2Transgenic chicken comprising an inactivated immunoglobulin geneCRYSTAL BIOSCIENCE INC·Filed 2017·Granted Jun 23, 2020·2 cites·12 claims
- 0878US10010058B2Transgenic animal for production of antibodies having minimal CDRSCRYSTAL BIOSCIENCE INC·Filed 2016·Granted Jul 3, 2018·1 cites·20 claims
- 0976US12408640B2Transgenic animal for producing diversified antibodies that have the same light chain ICRYSTAL BIOSCIENCE INC·Filed 2022·Granted Sep 9, 2025·0 cites·19 claims
- 1076US2025388651A1Transgenic chicken that makes antibodies with long cdr-h3s stabilized by multiple disulfide bridges and diversified by gene conversionCRYSTAL BIOSCIENCE INC·Filed 2025·Application pending·0 cites
- 1171US11542319B2Transgenic chicken comprising an inactivated immunoglobulin geneCRYSTAL BIOSCIENCE INC·Filed 2020·Granted Jan 3, 2023·0 cites·7 claims
- 1268US10362770B2Transgenic animal for production of antibodies having minimal CDRsCRYSTAL BIOSCIENCE INC·Filed 2018·Granted Jul 30, 2019·0 cites·15 claims
- 1363US12428471B2Transgenic chicken that makes antibodies with long CDR-H3S stabilized by multiple disulfide bridges and diversified by gene conversionCRYSTAL BIOSCIENCE INC·Filed 2019·Granted Sep 30, 2025·0 cites·10 claims
- 1461US2014127812A1Long-term culture of avian primordial germ cells (pgcs)SYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 1560US2014237633A1Germline transmission of avian primordial germ cells (pgcs)SYNAGEVA BIOPHARMA CORP·Filed 2014·Application pending·0 cites
- 1660US2005246782A1Transgenic aves producing human polyclonal antibodiesORIGEN THERAPEUTICS·Filed 2003·Application pending·0 cites
- 1759US2014155580A1Transgenic aves producing human polyclonal antibodiesSYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 1858US6248934B1Gene trap vectorsUNIV CALIFORNIA·Filed 1998·Granted Jun 19, 2001·14 cites·22 claims
- 1958US2010138946A1Transgenic chickens with an inactivated endogenous gene locusORIGEN THERAPEUTICS·Filed 2008·Application pending·0 cites
- 2058US2017086431A1Germline transmission of chicken primordial germ cells (pgcs)ALEXION PHARMA LLC·Filed 2016·Application pending·0 cites
- 2156US2017223938A1Transgenic chickens with an inactivated endogenous gene locusALEXION PHARMA INC·Filed 2016·Application pending·0 cites
- 2255US2014298504A1Transgenic chickens with an inactivated endogenous gene locusSYNAGEVA BIOPHARMA CORP·Filed 2014·Application pending·0 cites
- 2354US2016309686A1Transgenic birds that produce chimeric human immunoglobulinsLEIGHTON PHILIP A·Filed 2016·Application pending·0 cites
- 2454US2014289880A1Transgenic chickensSYNAGEVA BIOPHARMA CORP·Filed 2014·Application pending·0 cites
- 2553US2006174362A1Long-term culture of avian primordial germ cells (PGCs)ORIGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2652US2011277048A1Transgenic Aves Producing Human Polyclonal AntibodiesORIGEN THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2752US2014317765A1Transgenic birds that produce chimeric human immunoglobulinsLEIGHTON PHILIP A·Filed 2012·Application pending·0 cites
- 2850US2006206952A1Transgenic chickensORIGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2948US12102070B2Camelization of a human variable domain by gene conversionCRYSTAL BIOSCIENCE INC·Filed 2019·Granted Oct 1, 2024·0 cites·18 claims
- 3048US2006174363A1Germline transmission of avian primordial germ cells (PGCs)VAN DE LAVOIR MARIE-CECILE·Filed 2005·Application pending·0 cites
- 3146US2021000088A1Transgenic chicken that produces human antibodiesCRYSTAL BIOSCIENCE INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip A. Leighton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →